======= HRASLS2 =======
== Gene Information ==
* **Official Symbol**: PLAAT2
* **Official Name**: phospholipase A and acyltransferase 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54979|54979]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NWW9|Q9NWW9]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=HRASLS2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HRASLS2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/613866|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Exhibits PLA1/2 activity, catalyzing the calcium- independent hydrolysis of acyl groups in various phosphatidylcholines (PC) and phosphatidylethanolamine (PE). For most substrates, PLA1 activity is much higher than PLA2 activity. Catalyzes N-acylation of PE using both sn-1 and sn-2 palmitoyl groups of PC as acyl donor. Also catalyzes O-acylation converting lyso-PC into PC. {ECO:0000269|PubMed:19615464}.
|NC|
|1-acyl-2-lysophosphatidylserine acylhydrolase activity|
|N-acylphosphatidylethanolamine metabolic process|
|phosphatidylserine 1-acylhydrolase activity|
|N-acyltransferase activity|
|phospholipase A1 activity|
|phosphatidylethanolamine metabolic process|
|phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine)|
|phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine)|
|phosphatidylethanolamine acyl-chain remodeling|
|phospholipase A2 activity|
|phosphatidylcholine metabolic process|
|ammonium ion metabolic process|
|lipid catabolic process|
|glycerophospholipid metabolic process|
|phospholipid metabolic process|
|glycerolipid metabolic process|
|cellular amide metabolic process|
|organophosphate metabolic process|
|cellular lipid metabolic process|
|lipid metabolic process|
|organic substance catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp152|SGC2043 10μM R03 exp152]]|1.78|
|[[:results:exp232|Epothilone-D 0.004 to 0.006μM on day4 R05 exp232]]|1.86|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 6584
* **Expression level (log2 read counts)**: -7.68
{{:chemogenomics:nalm6 dist.png?nolink |}}